2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies

Research output: Contribution to journalArticle

27 Citations (Scopus)
Original languageEnglish
Pages (from-to)140-205
Number of pages66
JournalAtherosclerosis
Volume290
Early online date31 Aug 2019
DOIs
Publication statusPublished - 01 Nov 2019

Keywords

  • Apolipoprotein B
  • Cholesterol;
  • Dyslipidaemias
  • Familial hypercholesterolaemia
  • Guidelines
  • High-density lipoproteins
  • Lipoprotein remnants
  • Lipoprotein(a)
  • Low-density lipoproteins
  • Total cardiovascular risk
  • Treatment (adherence)
  • Treatment (drugs)
  • Treatment (lifestyle)
  • Triglycerides
  • Very low-density lipoproteins

Cite this

Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), & ESC National Cardiac Societies (2019). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 290, 140-205. https://doi.org/10.1016/j.atherosclerosis.2019.08.014